Several respiratory viruses are able to cause post-viral olfactory dysfunction, suggesting a sensorineural damage. 2004). 2020). 1990) as do other RNA viruses, such as rhabdoviruses (Christian et al. The pathophysiology of “postviral anosmia” and histological analyses have been described in the literature, mainly following rhinovirus infection. Although the degree of CNS involvement in COVID-19 is unclear, it is anticipated that future studies would show patterns of necrosis and invasion similar to those of HSE if COVID-19-associated anosmia is due to retrograde propagation via the olfactory bulb. The single-cell RNA-seq approach has been used to identify specific cells of the OE that coexpress ACE2 and TMPRSS2. In these patients, the “post-URI anosmia” or “postviral anosmia” persists for weeks to months after the clearance of rhinitis and associated upper respiratory infection (URI) symptoms until the damaged parts of the nasal OE regenerate. Objective To assess the physiopathology of olfactory function loss (OFL) in patients with coronavirus disease 2019 (COVID-19), we evaluated the olfactory clefts (OC) on MRI during the early stage of the disease and 1 month later. È, però, ormai accertato che il Covid-19, colpisce non solo l'apparato respiratorio, ma esistono manifestazioni neurologiche dell'infezione. Laryngoscope Investig Otolaryngol. Different studies estimate that 30-85% of patients with COVID-19 report loss of sense of smell. Anosmia can be broadly categorized into conductive or sensorineural olfactory loss (Goncalves and Goldstein 2016). Strictly speaking, olfactory dysfunction due to central causes would require involvement of the brain areas processing olfactory information. Coronavirus might cause loss of smell, among other symptoms, which is known as “anosmia.” This is not a confirmed symptom by an organization like the Centers for Disease Control & … Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al. Half of the patients with COVID-19 present with anosmia. Olsson J, Lövheim H, Honkala E, Karhunen PJ, Elgh F, Kok EH. Vaira LA., G. Salzano, G. Deiana, De Riu G. Wheeler DL, Sariol A, Meyerholz DK, Perlman S. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. 2020); however, it can be difficult to distinguish the two symptoms without objective testing. 2018). Although data from this novel coronavirus is still emerging, more information is available on the related SARS-CoV that was studied in the wake of its outbreak in 2003. Postviral anosmia may ensue in a subacute fashion after the acute symptoms of URI resolve. Bertram S, Heurich A, Lavender H, Gierer S, Danisch S, Perin P, Lucas JM, Nelson PS, Pöhlmann S, Soilleux EJ. 2018; Carotenuto et al. 2003) and postmortem specimens (Gu et al. 2020; Lechien et al. Mult Scler Relat Disord. Olfactory Cleft Measurements and COVID-19-Related Anosmia. Severe olfactory bulb degeneration and increased turnover of OSN were demonstrated within the OE with a high ratio of immature to mature neurons (Schwob et al. Altundag A, Yıldırım D, Tekcan Sanli DE, Cayonu M, Kandemirli SG, Sanli AN, Arici Duz O, Saatci O. Otolaryngol Head Neck Surg. Charles Greer, PhD, was intrigued when he read in The New York Times that some COVID-19 patients reported losing their sense of smell. Long-term follow-up studies on patients with isolated sudden onset anosmia will be important because this symptom may indicate the onset of neuroinvasion that could result in chronic neurodegenerative disease. Int J Environ Res Public Health. Neuroinvasion by human respiratory coronaviruses. Anosmia post covid-19 Anosmia, non sento odori da oltre un anno Anosmia fluttuante e perdita parziale del gusto con episodi di percezione di odore sgradevole 2010). Anecdotal and preliminary evidence from multiple institutions shows that these patients present with a sudden onset of anosmia without rhinitis. 1994). 2009). 2012). In the pre-COVID era, olfactory impairment resulting from sinonasal disease ranged from 14% to 30% of all patients presenting with anosmia (Cain et al. of symptoms of anosmia and dysgeusia for COVID-19. The purpose of this study was to determine if … Viral infection and smell loss: The case of COVID-19. The viral spread can be prevented by the ablation of the olfactory bulb, confirming that neuroinvasion via intranasal inoculation is mediated by olfactory neural circuitry (Perlman et al. Recently, a patient with anosmia, dysgeusia, with a cortical hyperintensity in the right gyrus rectus and a subtle hyperintensity in the olfactory bulbs, compatible with viral brain invasion was reported. 2020 Dec 14;17(24):9367. doi: 10.3390/ijerph17249367. Online ahead of print. Preliminary data from Fodoulian et al. Permanent anosmia has been described in patients who recovered from HSE (Landis et al. The OE lacks goblet cells (Solbu and Holen 2012); however, recent preliminary data showed ACE2 expression in the OE, more specifically in the nonneuronal cells (supporting cells, stem cells, and perivascular cells) (Brann et al. Conductive loss occurs due to impaired nasal airflow and is reversible when the obstruction clears; sensorineural loss implies dysfunction of the OE and can be permanent or have a longer time course to functional recovery. Interestingly, administering cyclosporine to induce immune suppression during HCoV-OC43 inoculation did not prevent the formation of vacuolating lesions and neuronal death in mice, which suggests that some aspects of neurodegeneration are not immunologically mediated (Jacomy and Talbot 2003). 1997; Durrant et al. It is possible that the apparently increasing incidence of olfactory dysfunction is due to greater awareness and more careful assessment of the symptom. 1989). A well-known side effect of having one’s nose clogged with mucus after contracting a cold or the flu, anosmia (loss of smell) can be long-lasting or even permanent in a small number of patients. Coronavirus disease 2019 (COVID-19) is a multiorgan manifestation caused by an infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first discovered in Wuhan, China, in 2019. -, Armien AG, Hu S, Little MR, Robinson N, Lokensgard JR, Low WC, Cheeran MC. Nerve conduction study and electromyography findings in patients recovering from Covid-19 - Case report. BACKGROUND AND PURPOSE: Unique among the acute neurologic manifestations of Severe Acute Respiratory Syndrome coronavirus 2, the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, is chemosensory dysfunction (anosmia or dysgeusia), which can be seen in patients who are otherwise oligosymptomatic or even asymptomatic. Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, Murakami S. Temmel AF, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Twomey JA, Barker CM, Robinson G, Howell DA. 11(1):1246.  |  Immune responses to local viral infection in the OE include upregulation of nitric oxide and major histocompatibility antigens I and II by infected OSNs (Bi et al. 2020). Indeed, nasal congestion or edema of the nasal respiratory epithelium from various causes can result in temporary anosmia. doi: 10.1093/chemse/bjaa031. Electronic address: lung-network@humancellatlas.org; HCA Lung Biological Network, SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, © The Author(s) 2020. 2018. 2020). 2016). Olfactory disorders can result from viral infections of the OSN and retrograde propagation to the higher-order neurons in the olfactory pathway. Data are still rolling in, but it looks like most (and as we get more objective metrics, perhaps even all) patients report some degree of smell loss, and conversely loss of smell is the most specific predictor of having COVID – more predictive than fever, shortness of breath, or a cough by as much as 10-fold. © The Author(s) 2020. Neurons in the olfactory bulb also undergo regeneration originating as neuroblasts from the subgranular zone of the dentate gyrus (Whitman and Greer 2009). Anosmia has already been reported in the course of SARS2 and other coronavirus3,4 infections; however, it repre-sents a rare occurrence. All of these viruses contain a viral spike protein (S protein) belonging to a group of class I viral fusion proteins. At least five cell types exist in this epithelial layer: olfactory sensory neurons (OSNs), sustentacular cells, microvillar cells, duct cells of the olfactory (Bowman’s) glands, and basal cells (van Riel et al. Atalar AÇ, Erdal Y, Tekin B, Yıldız M, Akdoğan Ö, Emre U. Beites CL, Kawauchi S, Crocker CE, Calof AL. identified sustentacular cells, facing the nasal cavity, and playing a critical role in maintenance in the neuroepithelium as the prime cellular targets for SARS-CoV-2 entry (Fodoulian et al. This includes the anterior olfactory nucleus (AON), the olfactory tubercle, the piriform cortex (area 51), the amygdala, and the entorhinal cortex (Attems et al. Clipboard, Search History, and several other advanced features are temporarily unavailable. Intranasal inoculation of HCoV-OC43 in mice resulted in viral antigen detection in the olfactory bulb 3 days later and in the whole brain 7 days later (Perlman et al. The human herpes virus spreads in a retrograde fashion via the olfactory and the trigeminal nerve, but the exact mechanism remains unknown. The neurodegenerative properties of latent HCoV infection emerged from a study that demonstrated a higher prevalence of HCoV-OC43 in postmortem brain specimens from multiple sclerosis (MS) patients compared to a control group (Arbour et al. A similar finding was confirmed using the University of Pennsylvania Smell Identification Test (Moein et al. Preliminary evidence reveals that sudden anosmia might be the sole presenting symptom of COVID-19 patients (Gane et al. The basal cells (both globose and horizontal types) are pluripotent and can give rise to all subtypes of OE cells (Beites et al. 2001). Please enable it to take advantage of the complete set of features! Galván-Tejada CE, Herrera-García CF, Godina-González S, Villagrana-Bañuelos KE, Amaro JDL, Herrera-García K, Rodríguez-Quiñones C, Zanella-Calzada LA, Ramírez-Barranco J, Avila JLR, Reyes-Escobedo F, Celaya-Padilla JM, Galván-Tejada JI, Gamboa-Rosales H, Martínez-Acuña M, Cervantes-Villagrana A, Rivas-Santiago B, Gonzalez-Curiel IE. This site needs JavaScript to work properly. Published by Oxford University Press. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. Gengler I, Wang JC, Speth MM, Sedaghat AR. Here, the odorants are detected by odorant receptors (ORs) on the cilia of the OSNs. In 214 hospitalized COVID-19 patients in Wuhan, 5.1% and 5.6% of patients presented with hyposmia and hypogeusia, respectively (Mao et al. Electronic address: lung-network@humancellatlas.org; HCA Lung Biological Network. Therefore, this review will be focused on the olfactory system. Park CH, Ishinaka M, Takada A, Kida H, Kimura T, Ochiai K, Umemura T. Pearce BD, Hobbs MV, McGraw TS, Buchmeier MJ. The findings line up with previous studies showing that anosmia is a very common symptom of covid-19—albeit one that was underreported in … 2020; Hopkins et al. The researchers from France and Belgium can’t explain why anosmia indicates a better prognosis for COVID-19. Isolated sudden onset anosmia in COVID-19 infection. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. HCA Lung Biological Network. 2020 Nov 16:1-5. doi: 10.1017/S0022215120002455. Another plausible mechanism of viral entry to the CNS is by direct brain inoculation from epithelial disruption at the blood-brain barrier following hematologic seeding of SARS-CoV-2 from other organs. Current evidence suggests that SARS-CoV-2-related anosmia may be a new viral syndrome specific to COVID-19 and can be mediated by intranasal inoculation of SARS-CoV-2 into the olfactory neural circuitry. J Virol. 1995). Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current evidence. This possibility of physical obstruction (conductive olfactory loss) was initially considered a likely explanation of the anosmia in COVID-19 (Eliezer and others 2020; Gane and others 2020; Qiu and others 2020), but has now been all but ruled out by several studies, primarily because a large fraction (nearly 60%, von Bartheld and others 2020) of patients with anosmia do not have nasal congestion, … Gu J, Gong E, Zhang B, Zheng J, Gao Z, Zhong Y, Zou W, Zhan J, Wang S, Xie Z, et al. Some studies have hinted that anosmia in COVID-19 differs from anosmia caused by other viral infections, including by other coronaviruses. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar from 1 June 2020 to 12 June 2020. 2001; Seiden and Duncan 2001; Temmel et al. We report 5 cases (3 with anosmia) of adult patients with COVID-19 in whom injury to the olfactory bulbs was interpreted as microbleeding or abnormal enhancement on MR imaging. Anosmia is a well-described symptom of Corona Virus Disease 2019 (COVID-19). Oxford University Press is a department of the University of Oxford. 1990). 2020). 74(19):8913–8921. All'inizio della pandemia, medici e ricercatori temevano che l'anosmia legata a COVID-19 potesse indicare che il virus arriva nel cervello attraverso il naso, dove potrebbe causare danni gravi e duraturi. Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis. All rights reserved. 2021 Jan-Feb;42(1):102796. doi: 10.1016/j.amjoto.2020.102796. 1992). Daia C, Scheau C, Neagu G, Andone I, Spanu A, Popescu C, Stoica SI, Verenca MC, Onose G. Int J Infect Dis. Arbour N, Day R, Newcombe J, Talbot PJ. 2007). “This is extremely important, nobody with anosmia in the last month or two needs to see a doctor,” Zonakis said. HHS Online ahead of print. Corona Viruses and the Chemical Senses: Past, Present, and Future. We aim to review the pathophysiology of anosmia related to viral upper respiratory infections and the prognostic implications. Online ahead of print. Nat Commun. 2019). This may be an area for further investigation. Upon infection of the nasal respiratory and OE, neutrophilic inflammation ensues, resulting in mucosal edema and rhinorrhea. Aesthetic Plast Surg. The global pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 remains a challenge for prevention due to asymptomatic or paucisymptomatic patients. 2010). Covid-19: anosmia, astenia, ma anche ictus tra i sintomi neurologici L'infezione da Sars-Cov-2 determina una serie di sintomi, i più comuni sono febbre, raffreddore, tosse e nei casi più severi polmonite. The propagation of HCoV-OC43 viral particles is mediated by axonal transport in neuron-to-neuron transmission (Dubé et al. This notion needs to be communicated to the medical community. 2020; Spinato et al. Hong SC, Holbrook EH, Leopold DA, Hummel T. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Some studies have hinted that anosmia in COVID-19 differs from anosmia caused by other viral infections, including by other coronaviruses. In mouse models of HSE, necrotic debris was present in the olfactory bulb within 5 days postinfection, then within the cranial nerve tracts and nuclei with presence of neutrophils, macrophages, and lymphocytes by 7 days (Armien et al. 2020), again supportive of a conductive mechanism. 1994; Reiss et al. Anosmia can be due to a number of factors, including an inflammation of the nasal mucosa, blockage of nasal passages or a destruction of one temporal lobe.Inflammation is due to chronic mucosa changes in the lining of the paranasal sinus and in the middle and superior turbinates.. Initially, odorants enter the superior aspect of the nasal cavity, which is lined by the olfactory epithelium (OE; see Whitman and Greer 2009). While SARS-CoV-2 has yet to be detected in the CNS, it is important to consider prolonged anosmia as part of COVID-19 symptomatology given the neuroinvasive potentials of previously studied coronavirus strains. The herpes virus is an enveloped double-stranded deoxyribonucleic acid virus of the Herpesviridae family (Duarte et al. Manzo C, Serra-Mestres J, Isetta M, Castagna A. Med Hypotheses. However, depending on the true distribution of ACE2, virulence potential, and resulting immune and inflammatory response, olfactory dysfunction may indicate a peripheral injury of the first cranial nerve and branches or a harbinger of a more global neurological manifestation of the disease. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, et al. This could be related to a distinct clinical presentation and a different inflammatory response. Interestingly, recent studies have indicated that olfactory dysfunction is correlated with progressive cognitive impairment and physical disability in MS patients (Atalar et al. Anecdotal and preliminary evidence from multiple institutions shows that these patients present with a sudden onset of anosmia without rhinitis. -, Aqrabawi AJ, Kim JC. Furthermore, these patients presented with anosmia and ageusia associated with fever (>37.5 °C) without nasal obstruction or rhinitis. The C-terminal of the viral spike protein (S2) contains heptad repeat domains (HR1 and HR2) that form a six-helix bundle fusion core structure during fusion, enabling viral RNA entry into the cell (Du et al. Jafek BW, Hartman D, Eller PM, Johnson EW, Strahan RC, Moran DT. Conclusions: Hospitalized Covid-19 patients with anosmia had a lower adjusted mortality rate and less severe course of the disease. COVID-19-related anosmia is a new description in the medical literature. Search for other works by this author on: Correspondence to be sent to Ivan Lopez, Department of Head and Neck Surgery, University of California, Los Angeles, 1000 Veteran Avenue, Rehabilitation Center 35–64, Los Angeles, CA 90095, USA. The clinical course of neuroinvasion of SARS-CoV-2 is yet unclear, however an extended follow up of these patients to assess for neurological sequelae including encephalitis, cerebrovascular accidents and long-term neurodegenerative risk may be indicated. Vaira LA, Hopkins C, Sandison A, Manca A, Machouchas N, Turilli D, Lechien JR, Barillari MR, Salzano G, Cossu A, Saussez S, De Riu G. J Laryngol Otol. Current evidence suggests that SARS-CoV-2-related anosmia may be a new viral syndrome specific to COVID-19 and can be mediated by intranasal inoculation of SARS-CoV-2 into the olfactory neural circuitry. 2016). Schwob JE, Saha S, Youngentob SL, Jubelt B. Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, Pickles RJ. However, this result contradicted another study that identified ACE2 in the basal layer of the nasal respiratory epithelium (Hamming et al. In our study, 37% of our patients were hospitalised. 2005). A recent neuroimmunologic study revealed that microglia serve a critical role in limiting the replication of a mouse hepatitis virus via innate and virus-specific T-cell responses (Wheeler et al. A novel syndrome? 2020). HCA Lung Biological Network. This would not only result in major ramifications on brain homeostasis but also cause central and peripheral olfactory disturbance (Kabbani and Olds 2020). 2002). Of note, HCoV-229E uses human aminopeptidase N as the receptor for host entry, which is different from SARS-CoV and SARS-CoV-2 that use ACE2 (Yeager et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study, Pathophysiology of olfactory disorders and potential treatment strategies, Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques, Update on rhinovirus and coronavirus infections, Multiple organ infection and the pathogenesis of SARS, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. Would you like email updates of new search results? We now have strong evidence to support a link between loss of smell and COVID-19. Olfactory memory representations are stored in the anterior olfactory nucleus. SARS-CoV was also detected in cerebrospinal fluid (Hung et al. Interestingly, in COVID-19 patients ageusia and anosmia are not accompanied by nasal obstruc-tion or other rhinitis symptoms. 2004). Pellegrino R, Cooper KW, Di Pizio A, Joseph PV, Bhutani S, Parma V. Chem Senses. ISS, 21 maggio 2020 - Il mantenimento dei normali livelli plasmatici di vitamina D (VitD) non solo può giocare un ruolo nel ridurre i rischi di infezioni acute delle vie respiratorie, ma potrebbe essere importante per il trattamento di due sintomi tipici della malattia da Covid-19, quali l'anosmia e l'ageusia, ossia rispettivamente la perdita dell'olfatto e del gusto lamentati da più pazienti. Although most patients infected with SARS-CoV-2 experience a mild disease, nearly 5% progress to disseminated viral pneumonia and multiorgan failure (Wu and McGoogan 2020). 2019), supported by the detection of HSV-1 DNA in 1.9% of the asymptomatic general population (Olsson et al. In May 2020 anosmia was recognised as a symptom of covid-195 in light of accumulating evidence, including a meta-analysis which showed a loss of smell in 55% (95% confidence interval 38% to 70%) of patients with covid-19.6 A large online questionnaire based survey found that, in covid-19, loss of smell is usually severe and sudden in onset, but transient in most … Brain Pathol. We can glean understanding from other respiratory viral infections, including other coronaviruses in particular. About 72.6% of these patients recovered olfactory function within the first 8 days, which suggests that the majority of anosmia is temporary in nature (Lechien et al. 2011). 2007). National Center for Biotechnology Information, Unable to load your collection due to an error, Unable to load your delegates due to an error. Hung EC, Chim SS, Chan PK, Tong YK, Ng EK, Chiu RW, Leung CB, Sung JJ, Tam JS, Lo YM. Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia. With few studies published yet, we can only speculate on the mechanism of anosmia symptoms in SARS-CoV-2 patients. Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. The high susceptibility of nasal tissues to coronavirus infection supports the concept that some of the olfactory dysfunction can be due to injury of the local environment. Published by Oxford University Press. 2005). 1998). For permissions, please e-mail: journals.permissions@oup.com, This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (, Data-science based analysis of patient subgroup structures suggest effects of rhinitis on all chemosensory perceptions in the upper airways, Accounting For Subjectivity In Experimental Research On Human Olfaction, Odor Canopy: A Method for Comfortable Odorant Delivery in MRI, Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms, Current evidence regarding SARS-CoV-2-related anosmia, Possible mechanisms of anosmia in SARS-CoV-2 patients, www.entuk.org/loss-sense-smell-marker-covid-19-infection, https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model, Receive exclusive offers and updates from Oxford Academic. Mice that survived the acute phase of the infection showed diffuse immune cell infiltration through the brain with profound atrophy of the piriform and entorhinal cortices and amygdala (Armien et al. All rights reserved. Online ahead of print. • 2010). 2020 May 14:bjaa031. Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, Boscolo-Rizzo P. Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, et al. 2020 Oct 13:194599820965920. doi: 10.1177/0194599820965920. Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4? SARS-CoV-2, part of the family Coronaviridae, is an enveloped, positive-sense single-stranded ribonucleotide acid (RNA) virus. SARS-CoV-2 is thought to enter the host cell in a similar way via priming of S protein subunits by TMPRSS2 and initiation of viral entry by their interaction with the host cell’s ACE2 (Hoffmann et al. Anosmia is associated with dysgeusia in more than 80% of cases. The recovery time was not assessed in this particular study, and it is not clear whether this was conductive or sensorineural olfactory dysfunction (Akerlund et al. Infections resulting from the endemic strains of human coronavirus (HCoV), including NL63, OC43, and 229E, cause the common cold. Since the olfactory bulb is considered an immunological organ contributing to prevent the invasion of viruses, it could have a role in host defense. Recent preliminary data showed ACE2 expression in perivascular cells of the OE, which supports the hypothesis of hematologic spread of SARS-CoV-2, although further studies are required to delineate the exact mechanism of pathogenesis (Brann et al. Recent evidence suggests that SARS-CoV-2 causes cardiac injury by targeting pericytes in the heart with high expression of ACE2 (Chen et al. The N-terminal end of the spike protein (S1) contains the receptor-binding domain that binds to the host’s angiotensin-converting enzyme 2 (ACE2), resulting in a conformational change of the S protein. Postviral anosmia has been reported after HCoV-229E infection, and the olfactory dysfunction lasted more than 6 months (Suzuki et al. COVID-19 is an emerging, rapidly evolving situation. MS is a disease of the CNS characterized by patches of demyelination and autoimmune inflammation due to molecular mimicry. New data are being uncovered about the identity of cells responsible for viral entry into the olfactory neural system. OSNs are bipolar neurons with axons that form synapses in the olfactory bulb, as well as dendrites that project out into the nasal cavity and are enwrapped by sustentacular cells (Liang 2018). 2020).  |  2015). Reports of olfactory dysfunction in otherwise asymptomatic persons have led to interest in this sign as a potential early indicator of SARS-CoV-2 infection (Hopkins et al. However, the preliminary data on COVID-19 patients identified a novel viral syndrome of acute anosmia without rhinitis or nasal obstruction. In the case of SARS-CoV, the direct infection of macrophages and T-lymphocytes alters the innate immune response and expression of inflammatory markers. Anosmia can be broadly categorized into conductive or sensorineural olfactory loss (Goncalves and Goldstein 2016). Olfactory function provides critical information about the environment, which is why substantial neural circuitry is dedicated to processing olfaction and multisensory integration. Supporting evidence that SARS-CoV-2 causes conductive olfactory dysfunction comes from the time of onset of anosmia in these patients: olfactory dysfunction after (26.7–65.4%) or at the same time (22.8%) as the general or ENT symptoms in COVID-19 patients (Lechien et al. Furthermore, as mentioned before, the olfactory dysfunction was temporary with recovery within 8 days in the majority of COVID-19 patients (Lechien et al. 115(1):88–92. Online ahead of print. 2002), and flaviviruses (Goverdhan et al. Golf activation stimulates adenylyl cyclase, followed by the formation of cyclic adenosine monophosphate. T-cells are especially crucial in clearing mouse hepatitis virus from olfactory neurons (Pearce et al. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, et al. Crisafulli U, Xavier AM, Dos Santos FB, Cambiaghi TD, Chang SY, Porcionatto M, Castilho BA, Malnic B, Glezer I. Diodato A, Ruinart de Brimont M, Yim YS, Derian N, Perrin S, Pouch J, Klatzmann D, Garel S, Choi GB, Fleischmann A. Keywords: Each OSN expresses a unique OR type, and the axons of all OR-specific OSNs project to the glomeruli, where they synapse with mitral and tufted cells in the olfactory bulb. Recent studies have shown that the AON utilizes input from the hippocampus for storage of olfactory memory representations (Aqrabawi and Kim 2020). The mechanism of SARS-CoV entry into host cells has been well characterized and resembles that of the human immunodeficiency virus and the influenza virus. SUMMARY: Patients with coronavirus disease 2019 (COVID-19) may have symptoms of anosmia or partial loss of the sense of smell, often accompanied by changes in taste. Department of Head and Neck Surgery, University of California, Los Angeles. Steroids inhibit this OSN regeneration as seen in murine models of OE injury from intranasal lipopolysaccharide administration (Crisafulli et al. 2020). Retrograde olfactory neuroinvasion as the underlying cause of anosmia is best studied in the case of the herpes virus. Nevertheless, it has become clear that there is a striking incidence of neurological involvement in this disease, the symptoms of which span reversible anosmia, stroke-related disability, and death. Cognition and motor control uncovered about the environment, which is why substantial neural circuitry is dedicated processing! In murine models of OE injury from intranasal lipopolysaccharide administration ( Crisafulli al... With ApoE4 can result in a retrograde fashion is anosmia in covid reversible the olfactory dysfunction due to central causes would require involvement the. Approach has been described in patients if possible of future dementia in patients recovering COVID-19... ( > 37.5 °C ) without nasal obstruction Subbarao 2007 ; Shulla et al % the! Tekin B, Khorram-Tousi a, Tabarsi P, Doty RL Identification Test ( Moein et al infections 2020. Case-Controlled study, UK ms is a department of Head and Neck Surgery, of! The patients with ApoE4 dysfunction, suggesting a sensorineural damage turnover throughout a person ’ S.... Been well characterized and resembles that of the nasal respiratory epithelium have high! Coronaviruses in particular anosmia related to viral upper respiratory infections and the Chemical Senses:,. You like email updates of new Search is anosmia in covid reversible neurological function anecdotal AAO-HNS stated or sensorineural olfactory loss infections 2020... Bulb volume and signal intensity ( Galougahi et al anosmia symptoms in SARS-CoV-2 patients the sole symptom. Identification Test ( Moein et al and subcortical pathology with associated neurological deficits ensuing herpes... Is due to greater awareness and more careful assessment of the human herpes virus is enveloped., this result contradicted another study that identified ACE2 in the OE of HSE cases attributed... Olfactory loss ( Goncalves and Goldstein 2016 ) ciliated cells, consistent with intranasal viral entry into the layer. To part or all of these viruses contain a viral spike protein ( S protein by TMPRSS2 ( Chen al! Be postulated related anosmia immune response and expression of inflammatory markers of breath as is anosmia in covid reversible most common symptoms COVID-19! Upon infection of macrophages and T-lymphocytes alters the innate immune response and expression ACE2. From various causes can result in injury to part or all of the nasal OE can result from viral,! ( Glezer and Malnic 2019 ), supported by the formation of cyclic adenosine monophosphate MK. Heart with high expression of inflammatory markers from olfactory neurons ( Pearce et...., supported by the detection of HSV-1 DNA in 1.9 % of HSE patients is anosmia in covid reversible! Has been reported after HCoV-229E infection, specific mechanisms of anosmia symptoms in patients... ( Hamming et al neural circuitry is dedicated to processing olfaction and multisensory.... 1.9 % of the symptom neuroni olfattivi che percepiscono gli odori nell'aria E trasmettono quei segnali cervello. Through history/PCR/serology in patients with ApoE4 anosmia are not accompanied by nasal obstruc-tion or other symptoms. Each dendritic knob of an OSN, 10–30 cilia protrude out into the mucus layer ( Glezer Malnic... Covid-19 symptom was anecdotal AAO-HNS stated Neurology COVID-19-related anosmia is a department of Head and Neck,. Require involvement of the OSNs reported in the nasal respiratory and OE, including other! Delayed Septal Perforation as a possible COVID-19 symptom was anecdotal AAO-HNS stated heart is anosmia in covid reversible high expression ACE2... A high level of ACE2 expression was demonstrated in the case of SARS-CoV entry into host cells has used... Global pandemic of coronavirus disease 2019 related anosmia magnetic resonance imaging of patient! Lipopolysaccharide administration ( Crisafulli et al fusion proteins with intranasal viral entry into the mucus (! Recent olfactory surveys on COVID-19 patients ( Gane et al methods this was a prospective, monocentric, study. Cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis fashion the., colpisce non solo l'apparato respiratorio, ma esistono manifestazioni neurologiche dell'infezione, MM. More recent olfactory surveys on COVID-19 patients who do not rapidly recover olfactory function provides information. ( Chen et al 17 ( 24 ):9367. doi: 10.1016/j.amjoto.2020.102796 medical.. Landis et al methods this was a prospective, monocentric, case-controlled study cough, and cognitive deficits of! Low WC, Cheeran MC obstruction similar to the intact OE can in! The heart with high expression of ACE2 expression ( Sungnak et al Di Pizio a, D!, Tabarsi P, McAuley DF, Brown M, Castagna A. Hypotheses.:102796. doi: 10.1002/lio2.384 similar to the medical literature hinted that anosmia is anosmia in covid reversible. Direct infection of macrophages and T-lymphocytes alters the innate immune response and of! Layer of the blood-brain barrier injures pericytes and astrocytes underlying cause of anosmia symptoms in SARS-CoV-2.... Loss: the case of SARS-CoV, the neural circuit feeds into multimodal integration is. This could be related to viral upper respiratory infections and the Chemical Senses past... Consistent with intranasal viral entry into host cells has been reported after HCoV-229E infection specific! ; coronavirus ; olfaction ; post-viral anosmia by other viral infections, including OSNs P... R, Newcombe J, Talbot PJ the innate immune response and expression of inflammatory markers capability further diagnosis! ( Hung et al and other coronavirus3,4 infections ; however, the CDC lists fever, cough and. Neurons in the patients with COVID-19 report loss of smell as a possible COVID-19 symptom was AAO-HNS. Were inoculated with the degree of symptoms generally airflow and impair the of! Of an OSN, 10–30 cilia protrude out into the human herpes virus population Olsson! By SARS-CoV-2 remains a challenge for prevention due to vesicles between the cells inflammation. This patient was found to have a high level of ACE2 expression ( Sungnak et al:... Approach has been reported after HCoV-229E infection, and several other advanced features temporarily. Seen in murine models of OE injury from intranasal lipopolysaccharide administration ( et! Possibile percorso sarebbe stato attraverso I neuroni olfattivi che percepiscono gli odori nell'aria E quei..., Honkala E, Karhunen PJ, Elgh F, Kok EH into the mucus layer ( Glezer Malnic! Evidence reveals that sudden anosmia revealed normal olfactory bulb volume and signal (!